BioNTech SE Description Of Growth Rate Used To Extrapolate Cash Flow Projections
BioNTech SE (BNTX) had Description Of Growth Rate Used To Extrapolate Cash Flow Projections of 1.50% as of 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes
ifrs-full:DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections · last filed 2026-03-10
- 2025-12-31: Description Of Growth Rate Used To Extrapolate Cash Flow Projections 1.50%.
- 2024-12-31: Description Of Growth Rate Used To Extrapolate Cash Flow Projections 1.50%.
- 2023-12-31: Description Of Growth Rate Used To Extrapolate Cash Flow Projections 1.00%.
- 2020-12-31: Description Of Growth Rate Used To Extrapolate Cash Flow Projections 1.00%.
| Period end | Description Of Growth Rate Used To Extrapolate Cash Flow Projections |
|---|---|
| 2025-12-31 | 1.50% 20-F · filed 2026-03-10 |
| 2024-12-31 | 1.50% 20-F · filed 2025-03-10 |
| 2023-12-31 | 1.00% 20-F · filed 2024-03-20 |
| 2020-12-31 | 1.00% 20-F · filed 2021-03-30 |